Delivery Order SPE2DB20D3101-SPE2DB20FH1D1
- Not listed
- This federal contract award is for a prime vendor pharmaceutical distribution contract with the Defense Logistics Agency (DLA) awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $2,286.30, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC enables Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,940.60 delivery order was issued by the Defense Logistics Agency (DLA) and has a firm fixed price. The contract supports the DLA Troop Support Medical program, providing a range of pharmaceutical products, medical devices, and other healthcare commodities to military treatment facilities and veterans' healthcare programs....
- This federal contract award is for a prime vendor pharmaceutical delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,612.42 firm fixed-price delivery order is to provide a wide range of pharmaceutical products and medical supplies in support of military healthcare programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,523.32 delivery order was awarded by the Defense Logistics Agency (DLA) for pharmaceutical and medical supply products to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award is for a prime vendor pharmaceutical delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,428.92 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 12, 2021, with a completion date of July 13, 2021. The contract is for the delivery of a variety of pharmaceutical products, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical supplies to support military treatment...
- This federal contract award is for a prime vendor pharmaceutical supply contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,274.77 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is for a prime vendor pharmaceutical contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,481.87 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $25,478.89 for a prime vendor pharmaceutical supply contract with the Defense Logistics Agency (DLA). The contract, which has no set-aside designation, is a firm fixed-price agreement to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items to...
- This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,108.29, was awarded by the Defense Logistics Agency (DLA) and is for the delivery of a broad range of pharmaceutical products, medical supplies, and equipment to support military and veterans' healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 16, 2021. The...
- This federal contract award is for a prime vendor pharmaceutical distribution contract with the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $2,048.10 delivery order for pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs. The contract has a period of performance through April 28, 2021 and is a firm fixed-price contract. There is no set-aside...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB20FH1D1Delivery Order
This federal contract award is for a prime vendor pharmaceutical contract from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,753.30 firm fixed-price delivery order supports the supply of a wide range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing these critical pharmaceutical and medical commodities to support the Department of Defense's healthcare needs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/17/20 |